Nitric oxide metabolites in exhaled breath condesate in patients with pollen allergy and bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 259s Year: 2004
The effect of antioxidant therapy on nitric oxide metabolites in exhaled breath condensate in patients with pollen allergy and bronchial asthma Source: Annual Congress 2007 - Airway regulation, provocation and monitoring - III Year: 2007
Concentrations of nitric oxide metabolites in the exhaled breath condensate in children with different bronchial asthma control Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012
Measurement of exhaled nitric oxide in rhinitic patients outside the pollen season Source: Annual Congress 2008 - Understanding airway inflammation Year: 2008
Cysteinyl leukotrienes in exhaled breath condensate are reduced after mite avoidance in allergic asthmatic children Source: Eur Respir J 2002; 20: Suppl. 38, 412s Year: 2002
Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma Source: Eur Respir J 2002; 20: 1393-1398 Year: 2002
The effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in the breath condensate of adults with mild asthma Source: Eur Respir J 2002; 20: Suppl. 38, 113s Year: 2002
Leukotrienes in exhaled breath condensate of children with asthma Source: Eur Respir J 2001; 18: Suppl. 33, 39s Year: 2001
Similar levels of nitric oxide in exhaled air in asthma and rhinitis after bronchial allergen challenge Source: Eur Respir J 2001; 18: Suppl. 33, 269s Year: 2001
Exhaled nitric oxide and lower airway involvement in persistent rhinitis Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum Year: 2006
Nasal nitric oxide, exhaled nitric oxide and exhaled breath condensate pH measurements in children with allergic disease Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement Year: 2008
Elevated exhaled nitric oxide without acidification of exhaled breath condensate in patients with mild asthma Source: Eur Respir J 2002; 20: Suppl. 38, 506s Year: 2002
Relationship between exhaled nitric oxide and biomarkers of atopy in children with allergic rhinitis Source: Eur Respir J 2004; 24: Suppl. 48, 271s Year: 2004
Exhaled bronchial NO and cysteinyl-leukotrienes in breath condensate in atopic children Source: Eur Respir J 2002; 20: Suppl. 38, 412s Year: 2002
Investigation of nitric oxide level in the exhaled breath condensate in asthma and COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 281s Year: 2005
Leukotrienes in exhaled breath condensate in childhood asthma Source: Eur Respir J 2003; 22: Suppl. 45, 398s Year: 2003
Exhaled nitric oxide (FENO) in patients with rhinitis and asthma-like symptoms Source: Eur Respir J 2005; 26: Suppl. 49, 280s Year: 2005
Relationship between fractional exhaled nitric oxide and nasal symptom in allergic rhinitis Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control Year: 2010
Levels of 8-isoprostane and LTB4 in exhaled breath condensate (EBC) in seasonal allergic rhinitis. Effect of therapy and allergen exposure Source: Eur Respir J 2004; 24: Suppl. 48, 678s Year: 2004
The effect of inhaled corticosteroid therapy on exhaled nitric oxide and exhaled hydrogen peroxide in asthma patients Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum Year: 2006